Favourable trends seen in stability of disability and clinically meaningful improvements in fatigue.BOSTON, May 19, 2026 ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces that patient ...

Detailed price information for Zenas Biopharma Inc (ZBIO-Q) from The Globe and Mail including charting and trades.

Favourable trends seen in stability of disability and clinically meaningful improvements in fatigue. BOSTON, May 19, 2026 ...

Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14 ...

Detailed price information for Zenas Biopharma Inc (ZBIO-Q) from The Globe and Mail including charting and trades.

The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Essentra PLC - Oxford, England-based manufacturer of plastic and ...

By David Bautz, PhD NASDAQ: TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonmya™ Update Tonix Pharmaceuticals ...

👉 Learn how to determine co-terminal angles given one angle. An angle is a figure formed by two rays that have a common endpoint. The two rays are called the sides of the angle while the common ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the first ...

Over the last several years, Apple has dramatically improved how it handles lithium-ion battery charging in iPhones, iPads, Macs, and Apple Watches. Across multiple system releases, the company moved ...